ZhuoShang Biotechnology Co., Ltd.
ZhuoShang Biotechnology Co., Ltd.
Previous
Next

MK-677

  • All products on this website support private label customization, including custom packaging and formulations. If you need any customized products, please click the contact information on the right to inquire for a quote, or leave your contact details and we will respond to you as soon as possible.

MK-677 (Ibutamoren) - Effects and Mechanism of Action

MK-677 is an orally active growth hormone secretagogue receptor agonist (GHSR agonist) that mimics the action of ghrelin, stimulating the pituitary gland to release growth hormone (GH) and insulin-like growth factor-1 (IGF-1). Below are its primary effects and research-supported applications:


1. Promotes Muscle Growth and Recovery

  • Increases Protein Synthesis: By elevating GH and IGF-1 levels, MK-677 enhances muscle protein synthesis while reducing catabolism, aiding muscle gain or preventing muscle loss.

  • Exercise Recovery: Clinical studies suggest it may accelerate post-workout muscle repair, particularly beneficial for athletes and strength trainers.


2. Improves Bone Health and Density

  • Stimulates Bone Formation: GH and IGF-1 are crucial for bone growth, and MK-677 may help increase bone density, reducing the risk of osteoporosis (especially in older adults).


3. Enhances Fat Metabolism

  • Reduces Body Fat: GH promotes fat breakdown, and MK-677 may assist in reducing subcutaneous fat, particularly when combined with exercise.


4. Improves Sleep and Recovery Quality

  • Extends Deep Sleep: By modulating the ghrelin pathway, MK-677 improves sleep architecture, increasing slow-wave sleep (deep sleep phase) and aiding physical recovery.


5. Potential Anti-Aging Effects

  • Enhances Skin and Collagen: Elevated GH levels may improve skin elasticity and reduce wrinkles (anecdotal user reports).

  • Slows Age-Related Decline: Animal studies suggest MK-677 may mitigate age-related muscle loss and cognitive decline, though human data remains limited.


Quick Inquiry